Dr. Consulta is a healthcare technology ("HealthTech") company providing low-cost care delivery to low-income patients with a multi-channel approach in Brazil.
The proposal consists of an equity investment of up to USD 12 million in Dr. Consulta Ltd. to support the entity to expand operations through the opening of new clinics, including other regions within Brazil, and to develop its technology and its recently acquired healthcare plans ("Cuidar.me").
The investment of up to US$10 million will take place as preferred convertible stock as part of the ongoing Series D equity round, with an estimated term of 7 years term. An additional 20% uncommitted amount may be contributed exclusively to exercise preemptive rights and/or right of first refusal.
ACCESS TO INFORMATION
You can submit a request for information disclosure at:
ACCOUNTABILITY MECHANISM OF IDB / IDB INVEST
The Independent Consultation and Investigation Mechanism (MICI) is the independent complaint mechanism and fact-finding body for people who have been or are likely to be adversely affected by an Inter-American Development Bank (IDB) or Inter-American Investment Corporation (IDB Invest)-funded project. If you submit a complaint to MICI, they may assist you in addressing the problems you raised through a dispute-resolution process with those implementing the project and/or through an investigation to assess whether the IDB or IDB Invest is following its own policies for preventing or mitigating harm to people or the environment. You can submit a complaint by sending an email to MICI@iadb.org. You can learn more about the MICI and how to file a complaint at http://www.iadb.org/en/mici/mici,1752.html (in English) or http://www.iadb.org/es/mici/mici,1752.html (Spanish).